NCT00784732View on ClinicalTrials.gov

A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

QAV680

DRUG

QAV680

DRUG

Mometasone Furoate

Trial Locations (1)

Unknown

Novartis Investigator Site, Toronto

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00784732 - A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber | Biotech Hunter | Biotech Hunter